Brijeshwar Maini, M.D., and Brian Bethea, M.D., from Tenet Florida’s structural heart program, explain the importance of building a good heart team and how that team should interact. They gave a presentation on image guidance for structural heart procedures at TCT 2016, but focused repeatedly on the need for close collaboration to be successful. Read more in the article "Requirements for Interventional Echocardiographers."
VIDEO: A Tour of the Artificial Intelligence Showcase at RSNA 2018
This is a quick video tour of the Machine Learning Showcase at the Radiological Society Of North America (RSNA) 2018 meeting today. More than 150 vendors showed software for radiology incorporating artificial intelligence (AI) or deep learning.
Read more in the article “How Artificial Intelligence Will Change Medical Imaging.”
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball Center for Innovation, explains the shortcomings of the first bioresorbable stent on the U.S. market, proper patient selection and what new BRS technologies are in development. Granada presented numerous sessions on bioresorbable scaffolds at TCT 2016. Read more about bioresorbable stents in "Tempering the Bioresorbable Stent Euphoria Following FDA Clearance of the Absorb."
Krishna Rocha-Singh, M.D., Prairie Vascular Institute, Springfield, Ill., explains advancements in device therapy for hypertension at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 annual meeting. He was involved in the SYMPLICITY HTN-3 denervation trial and is the principal investigator for the ongoing Rox Coupler arteriovenous device trial. Watch the VIDEO “New Approaches to Denervation Therapy.”
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute, Atlanta, Ga., explains the impact of the EXCEL Trial at TCT 2016. Piedmont recruited the highest number of patients for the large, randomized trial found the Xience V drug-eluting stent had comparable outcomes to coronary artery bypass graft surgery. This is the first time this parity has been shown in a large trial. Read the article "Stents, Bypass Surgery Equally Safe and Effective for Many With Left Main Heart Disease."
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due to emboli released during the procedure. Recent clinical data show the extent of this damage on MRI. Several TAVR embolic protection systems are being developed to reduce this damage. This video explains one of those systems. Read about trial data presented at TCT 2016 "Delirium Significantly Associated With Brain Lesions in Patients Post-TAVR." Read the article, “TAVR Embolic Protection Did Not Reduce Emboli Brain Lesions,” which was a second trial presented at TCT 2016.
This video, provided by Zoll, demonstrates how cardiologists can explain sudden cardiac death to patients. It is critical to educate patients who are at risk of sudden cardiac arrest (SCA), so Rahul Doshi, M.D., director of electrophysiology, associate professor of clinical medicine, Keck Medical Center of University of Southern California, explains sudden cardiac death (SCD) to his patients using a simple illustration. Visit SCDFacts.org for additional resources for you and your team to support the SCD conversation with your patients. One in five post-AMI patients have been shown to be at high risk of dying after PCI.1 The majority of mortality in AMI patients post-PCI occurs in the first three months — one out of every 10 high-risk patients die, with about 60 percent of this mortality due to SCD.[1,2]
With quality of care and cost efficiency at the top of your mind, there is no room in your hospital for waste from high-value supplies. However, managing your critical supplies in the cath lab can be a challenge. How can you get the supply waste in your facility under control? Watch this short video to learn how an automated inventory management solution could help you reduce the waste in your hospital while improving your total cost of care. For more information visit www.cardinalhealth.com.
This video, provided by Xeltis, demonstrates the world’s first bioresorbable heart valve enabling cardiovascular restoration for pediatric patients. The Xplore-I clinical study of Xeltis bioabsorbable pulmonary heart valve, is a a multi-centered feasibility trial currently enrolling pediatric patients from 2 to 21 years of age in leading heart centers in Europe. Read the article “First Bioresorbable Heart Valves Implanted to Enable Cardiovascular Restoration.”
With bundled payments putting increased pressure on hospitals to manage supply costs while providing quality patient care, there is no room in your cath lab for high-value medical device waste. An automated inventory management solution could help you find and reduce the waste hiding in your supply chain while helping to improve your total cost of care. Visit cardinalhealth.com/CIMS.
This video, provided by Shockwave Medical, demonstrates the Lithoplasty System. It uses ultrasonic waves to treatment calcified plaque in patients with peripheral artery disease (PAD). It was cleared by the U.S. FDA in September 2016. The technology is the first of its kind in interventional cardiovascular medicine. Using similar lithotripsy technology that is already in use to break up kidney stones, the balloon catheter cracks and breaks up calcium in vessel walls, without the need to over inflate the balloon, which can lead to extensive vessel damage. Read the article "FDA Clears Lithoplasty Balloon That Shatters Calcified Lesions With Ultrasound."
This video, provided by Respicardia, demonstrates the Remede System is a pacemaker-like implantable device. It is designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea. In this video from The Ohio State University, William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medical Center, explains how the technology works and highlights one patient case involved in a recent study of the device.
Pacemakers, stents and bandages — keeping tracking of what is on hand and accurately capturing charges can be a challenge. What if you could track, manage and analyze your cath lab inventory – low cost to high value – to reveal powerful business intelligence and shine a light on new savings and revenue capture?
This video, provided by Edwards Lifesciences, demonstrates the Intuity Elite surgical aortic valve, which uses a balloon expandable skirt technology taken from the Edwards Sapien TAVR valve. This enables rapid valve deployment without the need to suture the device in place. Read about the FDA approval of the valve in August 2016.
You have bigger priorities than managing inventory. Patient safety, quality care and clinician satisfaction top the list. But automated technology can help you improve the way you purchase, control and manage your cath lab inventory, allowing you to positively support your top priorities – and your hospital’s overall performance. For more information, watch this archived webinar on inventory management in the cath lab
Interview with Patricia Dickson, LRT (CT), assistant director, diagnostic and outpatient services, Capital Cardiology Associates, Albany, N.Y., at the Society of Cardiovascular Computed Tomography (SCCT) 2016 annual meeting. She explains what technologists need to know when prepping patients and imaging during cardiac CT exams. For trends in cardiac CT, watch the VIDEO "The Future of Cardiac CT in the Next Decade."
Interview with Claudio Smuclovisky, M.D., FACC, FSCCT, director of South Florida Imaging Cardiovascular Institute, Holy Cross Hospital, at the Society of Cardiovascular Computed Tomography (SCCT) 2016 annual meeting. Smuclovisky explains what imaging departments need to know about advances in CT systems when purchasing the newest generation of CT scanners. He explains there is more to scanners than slices, offering information beyond the hype over 64-, 128-, 256-, 320-, and 640-slice CT scanners. For more information, read "Costs vs. Benefits: Comparing 64-Slice to 256, 320-Slice CT."
An interview with Jonathan Leipsic, M.D., FSCCT, chairman of the department of radiology, St. Paul’s Hospital, Vancouver, Canada, at the Society of Cardiovascular Computed Tomography (SCCT) 2016 meeting. Leipsic is heavily involved with the procedural planning and anatomical assessments for TAVR and clinical trials for new transcatheter mitral valves and annulus repairs.
DAIC/ITN editor Dave Fornell shows some of the most innovative new cardiac CT and angiography technologies from sessions and the expo floor at the Society of Cardiovascular Computed Tomography (SCCT) 2016 annual meeting. Read the article "Advances in Cardiac CT Technology."
An interview with Matthew Budoff, M.D., FACC, director of cardiac CT, Harbor-UCLA Medical Center, Torrance, Calif., at the Society of Cardiovascular Computed Tomography (SCCT) 2016 meeting. Budoff explains how CT calcium scoring can be used to assess patients risk for coronary disease and if they should be on statin therapy. Read the 2017 article "Screening for Heart Disease May Lead to Prevention, Better Treatments."
An interview with Leslee Shaw, Ph.D, FACC, FASNC, FAHA, co-director of the Emory Clinical Cardiovascular Research Institute at the Society of Cardiovascular Computed Tomography (SCCT) 2016 meeting. Read the related article “Advances in Cardiac CT Technology."
An interview with Ricardo Cury, M.D., director of cardiac imaging, Miami Cardiac and Vascular Institute, at the Society of Cardiovascular Computed Tomography (SCCT) 2016 meeting. Cury who was instrumental in the development of the new CAD-RADS scoring system, which similar to BI-RADS used for breast imaging or LUNG-RADS use for assessment of lung diseases, is used to standardize the radiological assessment of coronary artery disease. For more information, read "Multi-Society Group Releases CAD-RADS for Standardized Coronary CT Angiography Reporting."
DAIC/ITN editor Dave Fornell shares some of the innovative new technologies on the show floor of the American Society of Echocardiography (ASE) 2016 annual meeting. Read the article "Top Trends in Cardiac Ultrasound."
Interview with Stephen Little, M.D., medical director of the Valve Clinic at the Houston Methodist DeBakey Heart and Vascular Center, at the American Society of Echocardiography (ASE) 2016 annual meeting. He explains the technologies his center is using to aid transcatheter structural heart procedure navigation, including TAVR, transcatheter mitral valve replacement (TMVR), LAA occlusion, and septal defect occlusions. Read the article “Requirements for Interventional Echocardiographers.” Also, watch the VIDEO "What is Required for Interventional Echo - Discussion With Rebecca Hahn."
Interview with Federico Asch, M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University, at the American Society of Echocardiography (ASE) 2016 annual meeting. Asch discusses the technology used for cardio-oncology cardiotoxcity assessments and how to set up these types of collaborative programs between oncology and cardiology. For more information, read the article Assessing Cardiotoxicity Due to Cancer Therapy.
Interview with MD Buyline clinical analysts Jon Brubaker and Sabrina Newell at the American Society of Echocardiography (ASE) 2016 annual meeting. They highlighted trends they have seen in cardiac strain imaging, 3-D echo, bubble contrast, interventional echo, structural heart, and point-of-care ultrasound. Read the article on trends from Brubaker and Newell - "Top Trends in Cardiac Ultrasound at ASE 2016."
Interview with Rebecca Hahn, M.D., FASE, Columbia University Medical Center, New York, at the American Society of Echocardiography (ASE) 2016 meeting. She is an expert in the new subspecialty of interventional echo and discussed considerations for hospitals thinking of creating interventional echo programs to help guide complex transcatheter structural heart procedures in the cath lab or hybrid OR. Read the article “Requirements for Interventional Echocardiographers.” Also, watch the related VIDEO "Transcatheter Structural Heart Procedure Navigation Technology Advances."
This is an animation, supplied by Gore, demonstrated how the Cardioform Septal Occluder is implanted for the transcatheter closure of ASDs or PFOs. It is a permanent implant consisting of a wire frame covered with a thin ePTFE membrane. The wire frame is made of a nitinol alloy. Read more about closing holes in the heart.
ITN/DAIC Editor Dave Fornell takes a tour of some of the most innovative new trends and health information technologies (IT) on the expo floor of the Healthcare Information and Management Systems Society (HIMSS) 2016 meeting. Technologies include radiation dose management, wearables, patient engagement, admission kiosks, analytics software and imaging workflow aids.
MD Buyline market analyst Jon Brubaker explained the new technology and trends he saw on the show floor at ACC.16.
Michael Jaff, M.D., medical director of Massachusetts General Hospital’s Fireman Vascular Center, explains the current trends and technologies in critical limb (CLI) ischemia at ACC.16. Jaff also discusses strategies used by hospitals to recruit patients into CLI programs. Read the article, "New Technologies to Treat Peripheral Artery Disease (PAD)."
Healthcare reform is changing the way you provide care. With a focus on cost efficiency and quality, tracking utilization and efficient inventory management are big opportunities in your cardiovascular suite to help you manage costs and support patient safety initiatives. See how using the right tool for the right supply is key to demonstrating ROI. Watch a webinar on cath lab inventory tracking — Stop the Emotional Stocking! Revitalize your Cath Lab.
DAIC Editor Dave Fornell takes a tour of some of the trends and interesting new technologies from the vendor booths on the expo floor at the 2016 meeting of the American College of Cardiology (ACC).
David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal Medicine, Division of Cardiovascular Diseases, shares details from his presentations at ACC.16 regarding the Watchman left atrial appendage occluder.
MDbuyline clinical analyst Tom Watson, BS, RCVT, explains the new hemodynamic system technology trends at ACC.16. All technologies are being increasingly integrated into the electronic medical record. Read the article “Improving Cath Lab Efficiency With Today’s Hemodynamic Systems.”
Chandan Devireddy, M.D., assistant professor of medicine at Emory Healthcare in Atlanta and an investigator in the PARTNER trials, discusses the positive late-breaking PARTNER II and IIA data presented at ACC.16. Among the key measures in these trials was the stroke rate, which is now the same as surgery.
John Carroll, M.D., professor of medicine at the University of Colorado School of Medicine, and director of interventional cardiology at the University of Colorado Hospital, explains his late-breaker presentation data at ACC.16. He researched outcomes and procedural volume based on the transcatheter aortic valve replacement (TAVR) STS/ACC TVT Registry.
Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New York-Presbyterian Hospital, explains ABSORB Trial data showing bioresorbable stents had poor outcomes in small coronary vessels. This might be included as a restriction in the instructions for use of the Abbott Absorb stent, which is currently pending FDA final review. Read the related article "Questions Remain on Future of Bioresorbable Stents." Also, read the article "FDA Approves First Totally Bioresorbable Stent."
A discussion on the adoption rate of FFR-CT with Dr. Campbell Rogers, chief medical officer of HeartFlow. It is the first vendor to gain FDA approval for noninvasive, virtual fractional flow reserve measurements derived from cardiac computed tomography scans. Read the article "Clinical Applications of FFR-CT."
Dr. Vinod Thourani, professor of surgery, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine and a co-investigator for the PARTNER II Trial, discusses the biggest news item from ACC.16 — the Sapien 3 TAVR device performed better that surgical aortic valve replacement.
Examples of clinical decision support software currently on the market that might be leveraged to address Stage 3 Meaningful Use from the expo floor of HIMSS 2016. Ascendian Healthcare Consulting CEO Shawn McKenzie also discusses how and why CDS should be integrated into the radiology workflow. Read the April 2017 article “CMS to Require Appropriate Use Criteria Documentation for Medical Imaging Orders.”